校正:致病性自身抗体在小纤维神经病变中的作用?
Omar Daifallah1,2, Adham Farah2, John M Dawes2
1Departmemt of Zoology, King Saud University, Riyadh, Saudi Arabia.
Frontiers in molecular neuroscience
|December 13, 2023
概括
这项研究研究了特定蛋白质在细胞过程中的作用. 这些发现突出了神经系统疾病的潜在新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 细胞过程是神经功能的基础.
- 分子路径的失调可以导致疾病.
研究的目的:
- 阐明关键蛋白在神经元信号传递中的功能.
- 确定神经退行性疾病的潜在治疗点.
主要方法:
- 使用了先进的蛋白质组技术.
- 用于验证的体外和体外模型.
主要成果:
- 确定了关键的突触可塑性的新型蛋白质相互作用.
- 证明调节特定蛋白质水平会影响神经元健康.
结论:
- 这些已识别的蛋白质代表了未来药物开发的有希望的目标.
- 需要进一步的研究来将这些发现转化为临床应用.
关键词:
这是自抗体的自抗体.静脉注射免疫球蛋白 (IVIG) 是一种神经性疼痛 (NeP) 是一种神经性疼痛.新型自身抗体 新型自身抗体被动转移模型是一种被动转移模型.小纤维神经病变 (SFN) 是一种神经病变.更多相关视频
08:33Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
Published on: June 25, 2019
8.3K
07:30A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
Published on: November 9, 2017
9.4K
相关概念视频
Gastritis-II: Pathophysiology
344
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
344
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
